Internal Medicine, Clinical Cardiatric Electrophysiology · Memphis, TN
NPI
1588753727
Since 2006
Specialty
Internal Medicine, Clinical Cardiatric Electrophysiology
Code 207RC0001X
Group practices
2
Medicare group memberships
Hospitals
3
Hospital affiliations
8060 Wolf River Blvd
Memphis, TN, 38138
Phone (901) 271-1000
Groups this clinician bills Medicare through
Medicare paid, 2024
$447K
12,481 services
Medicare patients, 2024
2,042
Average age 78
Drug cost, 2024
$1.9M
14,723 prescriptions
Company payments, 2025
$212
From 3 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mark A Coppess was code 99214 (office e&m - established), 1,945 times for 1,069 patients. In total Mark A Coppess billed 12,481 services in 64 codes, and Medicare paid $447K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2007-07-08.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99214 Office E&M - Established | Office | 1,945 | 1,069 | $81.64 | $159K |
| 93000 Electrocardiogram | Office | 1,930 | 1,093 | $9.15 | $18K |
| 93296 External Electrocardiographic Monitoring | Office | 1,625 | 614 | $13.22 | $21K |
| 93294 External Electrocardiographic Monitoring | Office | 1,201 | 463 | $19.11 | $23K |
| 93297 External Electrocardiographic Monitoring | Office | 1,048 | 189 | $39.89 | $42K |
| 99232 Hospital E&M - Subsequent | Facility | 602 | 257 | $57.75 | $35K |
| 85610 Clinical Chemistry | Office | 442 | 38 | $4.20 | $1,856 |
| 93295 External Electrocardiographic Monitoring | Office | 431 | 152 | $24.37 | $11K |
| 93793 Care Management/Coordination | Office | 403 | 32 | $6.70 | $2,701 |
| 93298 External Electrocardiographic Monitoring | Office | 390 | 60 | $67.16 | $26K |
| 93280 External Electrocardiographic Monitoring | Office | 293 | 254 | $24.38 | $7,144 |
| 99223 Hospital E&M - Initial | Facility | 210 | 195 | $125.86 | $26K |
| 99215 Office E&M - Established | Office | 170 | 137 | $114.59 | $19K |
| 36415 Venipuncture Blood Collection | Office | 156 | 132 | $8.60 | $1,342 |
| 99205 Office E&M - New | Office | 141 | 141 | $141.73 | $20K |
By year: 2022 $392K for 11,549 services; 2023 $399K for 12,268 services; 2024 $447K for 12,481 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85610 Clinical Chemistry | 442 | 38 | $4.20 | $1,856 |
| 36415 Venipuncture Blood Collection | 156 | 132 | $8.60 | $1,342 |
| 85025 Blood Count | 128 | 116 | $7.61 | $974 |
| 83735 Clinical Chemistry | 126 | 113 | $6.53 | $822 |
| 80053 Clinical Chemistry | 126 | 114 | $10.35 | $1,304 |
| 84443 Clinical Chemistry | 115 | 107 | $16.46 | $1,893 |
| 80061 Clinical Chemistry | 109 | 99 | $12.90 | $1,406 |
| 82550 Clinical Chemistry | 103 | 95 | $6.33 | $652 |
| 83036 Blood Count | 50 | 46 | $9.52 | $476 |
Medicare prescription drug claims, 2024
In 2024, the drug Mark A Coppess prescribed most often to Medicare patients was Eliquis (Apixaban), with 965 prescriptions and refills. In total Mark A Coppess wrote 14,723 Medicare prescriptions that cost $1.9M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Eliquis Apixaban | 965 | 1,824 | 231 | $1.0M |
| Atorvastatin Calcium Generic | 923 | 2,534 | 290 | $8,565 |
| Metoprolol Succinate Generic | 838 | 2,202 | 245 | $10K |
| Amlodipine Besylate Generic | 782 | 2,030 | 242 | $4,204 |
| Carvedilol Generic | 768 | 2,008 | 238 | $4,869 |
| Furosemide Generic | 680 | 1,749 | 234 | $3,295 |
| Rosuvastatin Calcium Generic | 641 | 1,744 | 209 | $11K |
| Losartan Potassium Generic | 591 | 1,617 | 185 | $6,289 |
| Lisinopril Generic | 553 | 1,478 | 172 | $3,318 |
| Hydrochlorothiazide Generic | 485 | 1,294 | 148 | $2,320 |
| Metoprolol Tartrate Generic | 459 | 1,142 | 141 | $1,865 |
| Amiodarone Hcl Generic | 433 | 1,050 | 130 | $5,314 |
| Pravastatin Sodium Generic | 418 | 1,142 | 133 | $4,663 |
| Potassium Chloride Generic | 415 | 1,006 | 129 | $6,544 |
| Flecainide Acetate Generic | 367 | 936 | 117 | $16K |
Brand drugs: 1,805 claims; generic drugs: 12,918 claims; opioid claims: 43.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mark A Coppess $212 ($212 in general payments such as food, travel and fees) from 3 companies. The largest payer was Medtronic, Inc. with $150.
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.